A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis
NCT02618616
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
129
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
ZPL-3893787
DRUG:
Placebo
Sponsor
Ziarco Pharma Ltd